Her doctor fought to keep her on the GLP-1 agonist, the category that includes weight loss and Type 2 diabetes drugs Ozempic, Wegovy, Mounjaro, and Zepbound
The ATP-PCr system is the dominant energy pathway for efforts lasting one to ten seconds, think maximal lifts, sprints, and explosive movements
Butyrate and phenylacetate as differentiating agents: practical problems and opportunities
Obesity has impacts on cardiovascular disease outcomes through increased risk of coronary artery disease, heart failure (more prominent with preserved ejection fraction), cardiac arrhythmias (most significantly atrial fibrillation), sudden death, and venous thromboembolism [7]
However, research is not considered conclusive